GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Earnings per Share (Diluted)

Betta Pharmaceuticals Co (SZSE:300558) Earnings per Share (Diluted) : ¥1.09 (TTM As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co Earnings per Share (Diluted)?

Betta Pharmaceuticals Co's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was ¥0.45. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1.09.

Betta Pharmaceuticals Co's EPS (Basic) for the three months ended in Sep. 2024 was ¥0.45. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1.09.

Betta Pharmaceuticals Co's EPS without NRI for the three months ended in Sep. 2024 was ¥0.36. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1.00.

During the past 12 months, Betta Pharmaceuticals Co's average EPS without NRIGrowth Rate was 47.10% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -8.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was -8.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was -8.00% per year.

During the past 13 years, Betta Pharmaceuticals Co's highest 3-Year average EPS without NRI Growth Rate was 33.40% per year. The lowest was -48.70% per year. And the median was -8.90% per year.


Betta Pharmaceuticals Co Earnings per Share (Diluted) Historical Data

The historical data trend for Betta Pharmaceuticals Co's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co Earnings per Share (Diluted) Chart

Betta Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.57 1.49 0.92 0.35 0.83

Betta Pharmaceuticals Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.10 0.23 0.31 0.45

Competitive Comparison of Betta Pharmaceuticals Co's Earnings per Share (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Betta Pharmaceuticals Co's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Betta Pharmaceuticals Co's PE Ratio falls into.



Betta Pharmaceuticals Co Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Betta Pharmaceuticals Co's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(348.032-0)/419.316
=0.83

Betta Pharmaceuticals Co's Earnings Per Share (Diluted) for the quarter that ended in Sep. 2024 is calculated as

Diluted Earnings Per Share (Q: Sep. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(192.278-0)/431.854
=0.45

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Betta Pharmaceuticals Co  (SZSE:300558) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Betta Pharmaceuticals Co Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Betta Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 355, Xingzhong Road, Economic and Technological Development Zone, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311100
Betta Pharmaceuticals Co Ltd is a pharmaceutical enterprise that focuses on the research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates in China.
Executives
Wang Jia Bing Directors, executives
Ding Lie Ming Directors, executives
Cai Wan Yu Executives

Betta Pharmaceuticals Co Headlines

No Headlines